<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <div xmlns="" tagx="article">
      <head>
         <style type="text/css"> table, tr, td {border : thin;}</style>
         <span class="citation_publisher">Frontiers Research Foundation</span>
         <h2 class="citation-title">Expression Regulation of Major Histocompatibility Complex Class I and Class II Encoding
            Genes
         </h2>
         <span class="doi">10.3389/fimmu.2011.00048</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Peter J. van den Elsen</span>
            <span class="citation_author_institution_ref">1</span>
         </div>
         <span class="email">[pjvdelsen@lumc.nl]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2011-10-04]</span>
         <span class="citation_copyright">[Copyright 2011: ]</span>
         <span class="citation_licence">[Licence This is an open-access article subject to a non-exclusive license between
            the authors and Frontiers Media SA, which permits use, distribution and reproduction
            in other forums, provided the original authors and source are credited and other Frontiers
            conditions are complied with.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Major histocompatibility complex (MHC)-I and MHC-II molecules play an essential role
            in the immune response to pathogens by virtue of their ability to present peptides
            to CD8
            <sup>+</sup> and CD4
            <sup>+</sup> T cells, respectively. Given this critical role, 
            <i>MHC-I</i> and 
            <i>MHC-II</i> genes are regulated in a tight fashion at the transcriptional level by a variety
            of transcription factors that interact with conserved cis-acting regulatory promoter
            elements. In addition to the activities of these regulatory factors, modification
            of chromatin also plays an essential role in the efficient transcription of these
            genes to meet with local requirement for an effective immune response. The focus of
            this review is on the transcription factors that interact with conserved cis-acting
            promoter elements and the epigenetic mechanisms that modulate induced and constitutive
            expression of these 
            <i>MHC</i> genes.
         </p>
      </div>
      <div id="">
         <h2>Introduction</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The products of the 
            <i>MHC class I (MHC-I)</i> and 
            <i>MHC class II (MHC-II)</i> genes encode cell-surface glycoproteins involved in the binding and presentation
            of peptides to the T cell receptors (TCRs) of T lymphocytes. Major histocompatibility
            complex (MHC)-I proteins present peptides from endogenous sources, such as those derived
            from viruses, to CD8
            <sup>+</sup> T cells, whereas MHC-II molecules mainly present peptides from exogenous sources,
            such as those derived from extracellular pathogens, to CD4
            <sup>+</sup> T cells. These tri-molecular interactions of MHC, peptide, and TCR are central to
            the generation of antigen-specific immune responses.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The 
            <i>MHC-I</i> gene cluster encodes the highly polymorphic classical MHC-I molecules (human leukocyte
            antigen, HLA-A, -B, and -C), which play essential roles in the detection and elimination
            of virus-infected cells, tumor cells and transplanted allogeneic cells and the less
            polymorphic non-classical MHC-Ib molecules (HLA-E, -F, and -G). These latter MHC-Ib
            molecules have specialized immune regulatory functions (Van den Elsen et al., 
            <span ref-type="bibr" rid="B83">
               <sup>
                  <a href="#B83">2004</a>
               </sup>
            </span>). All cell-surface expressed MHC-I and MHC-Ib molecules are associated with the non-polymorphic
            β2-microglobulin.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The MHC-II genes encode the polymorphic HLA-DR, -DQ, and -DP molecules, which are
            expressed as α- and β-chain heterodimers on the cell surface. MHC-II molecules are
            central in the initiation of cellular and humoral immune responses, but they have
            also been implicated as contributing factors for a variety of autoimmune disorders.
            In contrast to the classical MHC-I molecules, which are expressed in a constitutive
            fashion on almost all nucleated cells, the constitutive expression of MHC-II molecules
            is tissue-specific and is restricted to professional antigen presenting cells (APCs,
            i.e., dendritic cells, macrophages, and B cells) and in thymic epithelial cells (Van
            den Elsen et al., 
            <span ref-type="bibr" rid="B83">
               <sup>
                  <a href="#B83">2004</a>
               </sup>
            </span>). All other cell types lack constitutive expression of MHC-II molecules, but their
            expression can be induced by exposure to cytokines of which interferon γ (IFNγ) is
            the most potent, or upon activation, such as in human T cells (Holling et al., 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">2002</a>
               </sup>
            </span>; Wong et al., 
            <span ref-type="bibr" rid="B91">
               <sup>
                  <a href="#B91">2002</a>
               </sup>
            </span>). Because of their crucial role in the immune response, the genes encoding MHC-I
            and MHC-II molecules are tightly regulated at the transcriptional level both by genetic
            and epigenetic mechanisms.
         </p>
      </div>
      <div id="">
         <h2>Transcriptional Regulation of 
            <i>MHC</i> Genes
         </h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Activation of 
            <i>MHC-I</i> genes, with the exception of 
            <i>HLA-G</i>, is mediated by several conserved cis-acting regulatory promoter elements: i.e.,
            the enhancer A, interferon-stimulated response element (ISRE) and the SXY-module (comprising
            the S/W, X1, X2, and Y-boxes; Figure 
            <span ref-type="fig" rid="F1">1</span>). These conserved regulatory elements play an important role in the inducible and
            constitutive expression of 
            <i>MHC-I</i> genes (Van den Elsen et al., 
            <span ref-type="bibr" rid="B83">
               <sup>
                  <a href="#B83">2004</a>
               </sup>
            </span>). Interestingly, these regulatory elements are also involved in the transcriptional
            activation of the β2-microglobulin promoter but not of the promoters of the genes
            encoding the transporter associated with antigen processing (TAP) and the large multifunctional
            protease (LMP), which are essential components in the MHC-I antigen processing and
            presentation pathway (Gobin et al., 
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">1997</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">2001</a>
               </sup>
            </span>; Van den Elsen et al., 
            <span ref-type="bibr" rid="B83">
               <sup>
                  <a href="#B83">2004</a>
               </sup>
            </span>). In MHC-I promoters, the enhancer A is bound by nuclear factor (NF)-κB, while the
            ISRE is bound by interferon regulatory factor (IRF) family members (Figure 
            <span ref-type="fig" rid="F1">1</span>; Gobin et al., 
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">1998</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B22">
               <sup>
                  <a href="#B22">1999</a>
               </sup>
            </span>). The transcription factors NF-κB and IRF-1 are mediators of the TNFα and IFNγ (Janus-family
            kinase/signal transducer and activator of transcription, Jak/STAT) routes of gene
            activation, respectively, which account for the induced 
            <i>MHC-I</i> transcription. Additionally, binding sites for upstream-stimulatory factor (USF)-1,
            -2 and for the transcription factor Sp-1 can also be found within these upstream regulatory
            promoter elements in a locus and allele-specific fashion (Figure 
            <span ref-type="fig" rid="F1">1</span>; Gobin et al., 
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">1998</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B22">
               <sup>
                  <a href="#B22">1999</a>
               </sup>
            </span>). As a result of nucleotide sequence variation in the enhancer A and the ISRE in
            the different MHC-I promoters the level of promoter activation induced by these pathways
            differs among the various 
            <i>MHC-I</i> loci (Gobin et al., 
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">1998</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B22">
               <sup>
                  <a href="#B22">1999</a>
               </sup>
            </span>; Girdlestone, 
            <span ref-type="bibr" rid="B16">
               <sup>
                  <a href="#B16">2000</a>
               </sup>
            </span>; Johnson, 
            <span ref-type="bibr" rid="B35">
               <sup>
                  <a href="#B35">2003</a>
               </sup>
            </span>).
         </p>
         <div tagxxx="fig">
            <span class="label">Figure 1</span>
            <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
               <p>
                  <b>Schematic overview of the elements, interacting factors and epigenetic events governing
                     
                     <i>MHC-I</i> and 
                     <i>MHC-II</i> transcription
                  </b>. Shown is the shared proximal SXY-module, and the upstream enhancer A and ISRE typical
                  for MHC-I promoters with the exception of HLA-G. The proximal SXY-module is bound
                  by the MHC-enhanceosome.
               </p>
            </caption>
            <div tagxxx="graphic"></div>
         </div>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of 
            <i>HLA-G</i> is under normal circumstances confined primarily to fetal trophoblast cells and thymic
            epithelium. This suggest an alternative transcriptional control of 
            <i>HLA-G</i> than that of the classical 
            <i>MHC-I</i> genes. Indeed, while encoding similar regulatory elements in its 5′ DNA, 
            <i>HLA-G</i> is not regulated by the upstream ISRE and κB sites or the SXY regulatory module (Gobin
            and Van den Elsen, 
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">1999</a>
               </sup>
            </span>). Instead, the HLA-G promoter can be transactivated by the cyclic-AMP response element
            binding protein (CREB)-1 (Gobin et al., 
            <span ref-type="bibr" rid="B18">
               <sup>
                  <a href="#B18">2002</a>
               </sup>
            </span>). This transactivation is mediated by further upstream positioned CRE sites, which
            can bind CREB-1, activating transcription factor (ATF)-1 and c-Jun 
            <i>in vitro</i> (Figure 
            <span ref-type="fig" rid="F1">1</span>; Gobin et al., 
            <span ref-type="bibr" rid="B18">
               <sup>
                  <a href="#B18">2002</a>
               </sup>
            </span>). Since these factors are ubiquitously expressed, the lack of 
            <i>HLA-G</i> expression in cell types other than trophoblast cells must be regulated in a different
            manner such as by alternative regulatory factors that suppress expression of 
            <i>HLA-G</i> or by epigenetic mechanisms. In this respect it was recently shown that Ras-responsive
            binding protein-1 (RREB-1) is a transcriptional repressor of 
            <i>HLA-G</i>, which exerts its function through chromatin remodeling of the 
            <i>HLA-G</i> locus by virtue of its interaction with subunits of the CtBP complex in cells that
            lack expression of 
            <i>HLA-G</i> (Flajollet et al., 
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">2009</a>
               </sup>
            </span>). Additionally, it has also been demonstrated that treatment of various types of
            cells lacking 
            <i>HLA-G</i> expression with the DNA methyltransferase inhibitor 5′-AZA-deoxycytidine results
            in restoration of 
            <i>HLA-G</i> transcription (Moreau et al., 
            <span ref-type="bibr" rid="B55">
               <sup>
                  <a href="#B55">2003</a>
               </sup>
            </span>). Besides DNA methylation, histone acetylation modifications have also been implicated
            in the transcriptional control of 
            <i>HLA-G</i> in trophoblast cell lines (Holling et al., 
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">2009</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The SXY-module is also present is the promoters of 
            <i>MHC-II</i> and its accessory genes (
            <i>invariant chain</i>, 
            <i>HLA-DM</i> and 
            <i>HLA-DO</i>). However, MHC-II promoters differ from MHC-I promoters in that they lack the typical
            enhancer A and ISRE (Figure 
            <span ref-type="fig" rid="F1">1</span>). The sequence and stereo-specific alignment of the various boxes in the SXY-module
            is highly conserved and critical for its functioning in constitutive and inducible-transcriptional
            activation of 
            <i>MHC-I</i> and 
            <i>MHC-II</i> genes (Gobin et al., 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">2001</a>
               </sup>
            </span>; Ting and Trowsdale, 
            <span ref-type="bibr" rid="B80">
               <sup>
                  <a href="#B80">2002</a>
               </sup>
            </span>). The SXY-module is cooperatively bound by a multi-protein complex containing regulatory
            factor X (RFX; consisting of RFX5, RFXB/ANK, and RFXAP; Steimle et al., 
            <span ref-type="bibr" rid="B78">
               <sup>
                  <a href="#B78">1995</a>
               </sup>
            </span>; Durand et al., 
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">1997</a>
               </sup>
            </span>; Masternak et al., 
            <span ref-type="bibr" rid="B49">
               <sup>
                  <a href="#B49">1998</a>
               </sup>
            </span>; Nagarajan et al., 
            <span ref-type="bibr" rid="B65">
               <sup>
                  <a href="#B65">1999</a>
               </sup>
            </span>), CREB/ATF (Moreno et al., 
            <span ref-type="bibr" rid="B56">
               <sup>
                  <a href="#B56">1999</a>
               </sup>
            </span>; Gobin et al., 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">2001</a>
               </sup>
            </span>), and nuclear factor-Y (NF-Y; Louis-Plence et al., 
            <span ref-type="bibr" rid="B43">
               <sup>
                  <a href="#B43">1997</a>
               </sup>
            </span>; Jabrane-Ferrat et al., 
            <span ref-type="bibr" rid="B34">
               <sup>
                  <a href="#B34">2002</a>
               </sup>
            </span>). This complex acts as an enhanceosome driving transactivation of these genes (Masternak
            et al., 
            <span ref-type="bibr" rid="B50">
               <sup>
                  <a href="#B50">2000</a>
               </sup>
            </span>; Gobin et al., 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">2001</a>
               </sup>
            </span>; Choi et al., 
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">2011</a>
               </sup>
            </span>). The presence of the RFX components is crucial for the assembly of this enhanceosome,
            a notion that has been derived from studies with cell lines established from MHC-II
            deficiency patients (Reith and Mach, 
            <span ref-type="bibr" rid="B72">
               <sup>
                  <a href="#B72">2001</a>
               </sup>
            </span>). In addition to these factors that assemble directly to the X1, X2, and Y-box sequences
            the class II transactivator (CIITA), which acts as a co-activator, is also required.
            CIITA is essential for 
            <i>MHC-II</i> transcription (Steimle et al., 
            <span ref-type="bibr" rid="B79">
               <sup>
                  <a href="#B79">1993</a>
               </sup>
            </span>), while it contributes to the activation of MHC-I promoters (Gobin et al., 
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">1997</a>
               </sup>
            </span>; Martin et al., 
            <span ref-type="bibr" rid="B48">
               <sup>
                  <a href="#B48">1997</a>
               </sup>
            </span>). CIITA belongs to the large NLR (nucleotide binding domain, leucine-rich repeat
            containing) family of proteins that play multiple functions in innate immune responses
            (Harton et al., 
            <span ref-type="bibr" rid="B26">
               <sup>
                  <a href="#B26">2002</a>
               </sup>
            </span>; Ting et al., 
            <span ref-type="bibr" rid="B81">
               <sup>
                  <a href="#B81">2008</a>
               </sup>
            </span>). Despite the fact that CIITA activates MHC-I promoters 
            <i>in vitro</i>, its 
            <i>in vivo</i> contribution to 
            <i>MHC-I</i> gene transcription remained enigmatic. It is therefore of note that more recently
            the NLR family member NLRC5 was identified to associate with and activate the promoters
            of 
            <i>MHC-I</i> genes and not 
            <i>MHC-II</i> genes 
            <i>in vivo</i> (Meissner et al., 
            <span ref-type="bibr" rid="B54">
               <sup>
                  <a href="#B54">2010</a>
               </sup>
            </span>). Like CIITA, NLRC5 also induced the expression of the gene encoding β2-microglobulin.
            However, in contrast to CIITA, NLRC5 was also found to control the expression of the
            genes encoding TAP and LMP. These observations reveal that NLRC5 appears to be a transcriptional
            regulator, which orchestrates the concerted expression of critical components in the
            MHC-I antigen presentation pathway (Meissner et al., 
            <span ref-type="bibr" rid="B54">
               <sup>
                  <a href="#B54">2010</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Given the essential role of CIITA in 
            <i>MHC-II</i> transcription, constitutive expression of CIITA coincides with constitutive MHC-II
            molecule expression in APCs. In non-immune cells expression of CIITA can be induced
            by IFNγ resulting in inducible MHC-II expression at the cell surface. CIITA therefore
            can be regarded as a molecular switch for MHC-II expression. Transcriptional activation
            of 
            <i>MHC-II</i> genes also involves modulation of covalent histones modifications and chromatin remodeling
            (Choi et al., 
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">2011</a>
               </sup>
            </span>). As an example, IFNγ-induced MHC-II expression results in an increase in active
            histone marks, i.e., acetylation of histone H3 and H4, and 3meK4-H3 at the MHC-II
            promoter, while at the same time a decrease in the repressive 3meK9-H3 histone mark
            is noted (Chou and Tomasi, 
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">2008</a>
               </sup>
            </span>).
         </p>
      </div>
      <div id="">
         <h2>CIITA Transactivation and Epigenetic Activities</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Class II transactivator exerts its transactivating function through protein–protein
            interactions with the components of the MHC-enhanceosome bound to the proximal SXY
            regulatory module in MHC promoters (Figure 
            <span ref-type="fig" rid="F1">1</span>; Masternak et al., 
            <span ref-type="bibr" rid="B50">
               <sup>
                  <a href="#B50">2000</a>
               </sup>
            </span>; Zhu et al., 
            <span ref-type="bibr" rid="B95">
               <sup>
                  <a href="#B95">2000</a>
               </sup>
            </span>; Jabrane-Ferrat et al., 
            <span ref-type="bibr" rid="B33">
               <sup>
                  <a href="#B33">2003</a>
               </sup>
            </span>). This interaction of CIITA with the MHC-enhanceosome allows for the subsequent recruitment
            of the lysine acetyltransferases (KATs) p300 (KAT3b)/CREB binding protein (CBP or
            KAT3a) and p300/CBP-associated factor (PCAF or KAT2b), which promote transcription
            of 
            <i>MHC-I</i> and 
            <i>MHC-II</i> genes by providing a more open chromatin structure (Kretsovali et al., 
            <span ref-type="bibr" rid="B41">
               <sup>
                  <a href="#B41">1998</a>
               </sup>
            </span>; Fontes et al., 
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">1999</a>
               </sup>
            </span>; Spilianakis et al., 
            <span ref-type="bibr" rid="B77">
               <sup>
                  <a href="#B77">2000</a>
               </sup>
            </span>; Gobin et al., 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">2001</a>
               </sup>
            </span>). Furthermore, CIITA also recruits the co-activator-associated arginine methyltransferase-1/protein
            arginine 
            <i>N</i>-methyltransferase 4 (CARM1/PRMT4; Zika and Ting, 
            <span ref-type="bibr" rid="B98">
               <sup>
                  <a href="#B98">2005</a>
               </sup>
            </span>; Zika et al., 
            <span ref-type="bibr" rid="B96">
               <sup>
                  <a href="#B96">2005</a>
               </sup>
            </span>; Figure 
            <span ref-type="fig" rid="F1">1</span>). Besides acting as a platform for recruitment of KAT activities, CIITA itself contains
            intrinsic KAT activity. The CIITA-mediated transactivation of MHC promoters was found
            to rely on this intrinsic KAT activity, which maps to a region in its N-terminus (Raval
            et al., 
            <span ref-type="bibr" rid="B71">
               <sup>
                  <a href="#B71">2001</a>
               </sup>
            </span>). This KAT activity of CIITA is regulated by its C-terminal GTP-binding domain and
            is stimulated by GTP (Raval et al., 
            <span ref-type="bibr" rid="B71">
               <sup>
                  <a href="#B71">2001</a>
               </sup>
            </span>). Interestingly, the CIITA KAT activity was found to bypass TATA box binding protein
            (TBP)-associated factor 250 kDa (TAF
            <div tagxxx="sub">II</div>250) in MHC-I promoter activation (Raval et al., 
            <span ref-type="bibr" rid="B71">
               <sup>
                  <a href="#B71">2001</a>
               </sup>
            </span>). Moreover, acetylation of CIITA itself by CBP and/or PCAF at specific lysine residues
            within the bipartite nuclear localization signal in the amino-terminal region of CIITA
            governs its nuclear accumulation (Spilianakis et al., 
            <span ref-type="bibr" rid="B77">
               <sup>
                  <a href="#B77">2000</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Class II transactivator also interacts with histone deacetylases (HDACs), which were
            found to interfere with CIITA function. These activities that acetylate/deacetylate
            lysine residues act as molecular switches for CIITA-mediated transcriptional activation/silencing
            of 
            <i>MHC</i> genes. In this respect, it was found that HDAC1 and HDAC2 interfere in the transcriptional
            transactivation function of CIITA following IFNγ induction (Zika et al., 
            <span ref-type="bibr" rid="B97">
               <sup>
                  <a href="#B97">2003</a>
               </sup>
            </span>; Kong et al., 
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">2009</a>
               </sup>
            </span>). In mice the HDAC1/HDAC2-associated repressor SIN3 homolog A (mSin3A) amplifies
            this inhibition in CIITA function (Zika et al., 
            <span ref-type="bibr" rid="B97">
               <sup>
                  <a href="#B97">2003</a>
               </sup>
            </span>). HDAC2 has the potential to deacetylate CIITA through its interaction with CIITA
            (Kong et al., 
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">2009</a>
               </sup>
            </span>). This results in targeting of CIITA to the proteasomal degradation machinery and
            decreased interaction of CIITA with the RFX component RFX5 (Kong et al., 
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">2009</a>
               </sup>
            </span>). Together, these observations reveal that these HDAC activities affect CIITA function
            on the one hand by disrupting assembly of the MHC-enhanceosome, while on the other
            hand they interfere in CIITA interactions with the MHC-enhanceosome. The switch/sucrose
            non-fermentable (SWI/SNF) ATPase Brahma-related gene-1 (BRG-1) also associates with
            CIITA and is required for the CIITA-mediated induction of 
            <i>MHC-II</i> genes (Mudhasani and Fontes, 
            <span ref-type="bibr" rid="B60">
               <sup>
                  <a href="#B60">2002</a>
               </sup>
            </span>). The association of CIITA and BRG-1 suggest that the ATP-dependent chromatin remodeling
            SWI/SNF complex is recruited by CIITA to MHC-II promoters to control transcription
            of 
            <i>MHC-II</i> genes. The ATPase Sug 1, a component of the 19S proteasome (19S P) complex, was found
            to be involved in increased levels of acetylation at MHC-II promoters and appeared
            to be essential for CIITA stability and 
            <i>MHC-II</i> expression (Bhat et al., 
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">2008</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2010a</a>
               </sup>
            </span>; Koues et al., 
            <span ref-type="bibr" rid="B38">
               <sup>
                  <a href="#B38">2008</a>
               </sup>
            </span>). More recently, another subunit of the 19S proteosome complex, the ATPase S6a (S6′/Tat-binding
            protein 1), was found to be crucial for regulating cytokine-inducible transcription
            of CIITA thereby indirectly modulation 
            <i>MHC-II</i> transcription (Truax et al., 
            <span ref-type="bibr" rid="B82">
               <sup>
                  <a href="#B82">2010</a>
               </sup>
            </span>). Other activities involved monoubiquitination of CIITA, which was shown to stabilize
            CIITA at MHC-II promoters (Bhat et al., 
            <span ref-type="bibr" rid="B3">
               <sup>
                  <a href="#B3">2010b</a>
               </sup>
            </span>). In addition MLL/COMPASS subunits, which are involved in establishing active histone
            H3-K4 methylation marks, were found also to be recruited to MHC-II promoters following
            IFNγ treatment of cells (Koues et al., 
            <span ref-type="bibr" rid="B39">
               <sup>
                  <a href="#B39">2010</a>
               </sup>
            </span>; Figure 
            <span ref-type="fig" rid="F1">1</span>).
         </p>
      </div>
      <div id="">
         <h2>Long-Range Promoter Interactions</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The appropriate temporal and spatial expression of 
            <i>MHC-II</i> genes 
            <i>in vivo</i> also requires the involvement of additional, long-range regulatory elements. The
            more distal X–Y or X-box like sequences in the 
            <i>MHC-II</i> region play an important role in these processes (Gomez et al., 
            <span ref-type="bibr" rid="B23">
               <sup>
                  <a href="#B23">2005</a>
               </sup>
            </span>). It has been found that interactions between the proximal elements and more distal
            X–Y or X-box like sequences (2.3 kb upstream of the HLA-DRA promoter) result in epigenetic
            changes at the MHC-II promoter (Masternak et al., 
            <span ref-type="bibr" rid="B51">
               <sup>
                  <a href="#B51">2003</a>
               </sup>
            </span>; Wright and Ting, 
            <span ref-type="bibr" rid="B92">
               <sup>
                  <a href="#B92">2006</a>
               </sup>
            </span>; Choi et al., 
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">2011</a>
               </sup>
            </span>). In one model, RFX and CIITA can interact with the proximal SXY-module and with
            distal X–Y or X-box like sequences to form a chromatin loop (Masternak et al., 
            <span ref-type="bibr" rid="B51">
               <sup>
                  <a href="#B51">2003</a>
               </sup>
            </span>). This chromatin loop results in enhanced histone acetylation (Krawczyk et al., 
            <span ref-type="bibr" rid="B40">
               <sup>
                  <a href="#B40">2004</a>
               </sup>
            </span>). Likewise, the transcriptional insulator factor CCCTC binding factor insulator (CTCF)
            was found to control 
            <i>MHC-II</i> gene expression through long-distance chromatin interactions (Majumder et al., 
            <span ref-type="bibr" rid="B47">
               <sup>
                  <a href="#B47">2008</a>
               </sup>
            </span>). The intergenic DNA of the 
            <i>HLA-DRB1</i> and 
            <i>HLA-DQA1</i> genes hosts a region that was bound by CTCF and acts as a potent enhancer-blocking
            element (Majumder et al., 
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">2006</a>
               </sup>
            </span>). This element and its bound factors were found to interact with 
            <i>HLA-DRB1</i> and 
            <i>HLA-DQA1</i> (Majumder et al., 
            <span ref-type="bibr" rid="B47">
               <sup>
                  <a href="#B47">2008</a>
               </sup>
            </span>). Subsequently it was demonstrated that CTCF associates with CIITA and RFX5 suggesting
            that the CTCF bound region and the flanking HLA-DRB1 and HLA-DQA1 proximal promoters
            may interact (Majumder et al., 
            <span ref-type="bibr" rid="B47">
               <sup>
                  <a href="#B47">2008</a>
               </sup>
            </span>). More recently it was shown by RNAi depletion of CTCF that all CIITA-regulated genes
            within the 
            <i>MHC-II</i> locus required CTCF for maximal expression (Majumder and Boss, 
            <span ref-type="bibr" rid="B45">
               <sup>
                  <a href="#B45">2010</a>
               </sup>
            </span>).
         </p>
      </div>
      <div id="">
         <h2>Epigenetic Regulation of 
            <i>MHC2TA</i> Transcription
         </h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Transcriptional regulation of 
            <i>MHC2TA</i>, the gene encoding CIITA, is mediated through the activity of four independent promoter
            units (CIITA-PI through CIITA-PIV; Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B62">
               <sup>
                  <a href="#B62">1997</a>
               </sup>
            </span>; Figure 
            <span ref-type="fig" rid="F2">2</span>). These promoter units are employed in a cell type- and activation-specific manner.
            CIITA-PI and CIITA-PIII are used for the constitutive expression in dendritic cells
            and in B cells, respectively (Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B62">
               <sup>
                  <a href="#B62">1997</a>
               </sup>
            </span>). CIITA-PIV has been shown to be the promoter predominantly involved in IFNγ-inducible
            expression (Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B61">
               <sup>
                  <a href="#B61">1998</a>
               </sup>
            </span>; Piskurich et al., 
            <span ref-type="bibr" rid="B70">
               <sup>
                  <a href="#B70">1998</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B69">
               <sup>
                  <a href="#B69">1999</a>
               </sup>
            </span>). In addition, in human non-B cells, CIITA-PIII can also be activated by IFNγ through
            an element located 2 kb upstream of the core CIITA-PIII promoter (Piskurich et al.,
            
            <span ref-type="bibr" rid="B69">
               <sup>
                  <a href="#B69">1999</a>
               </sup>
            </span>; Van der Stoep et al., 
            <span ref-type="bibr" rid="B88">
               <sup>
                  <a href="#B88">2002a</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B86">
               <sup>
                  <a href="#B86">2007</a>
               </sup>
            </span>). CIITA-PIII has also been shown to be employed by human T cells upon activation
            (Holling et al., 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">2002</a>
               </sup>
            </span>; Wong et al., 
            <span ref-type="bibr" rid="B91">
               <sup>
                  <a href="#B91">2002</a>
               </sup>
            </span>). The promoter function of CIITA-PII is still ill-defined. The various 
            <i>MHC2TA</i> promoters each transcribe a unique first exon and are located within a region of
            approximately 14 kb (Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B62">
               <sup>
                  <a href="#B62">1997</a>
               </sup>
            </span>).
         </p>
         <div tagxxx="fig">
            <span class="label">Figure 2</span>
            <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
               <p>
                  <b>Schematic overview of the 
                     <i>MHC2TA</i> multi-promoter region
                  </b>. Shown are the factors and elements governing transactivation of CIITA-PI in immature
                  dendritic cells, CIITA-PIII in B cells and CIITA-PIV following IFNγ stimulation. The
                  localization of the various protein/DNA-binding elements is indicated relative to
                  the transcription start site.
               </p>
            </caption>
            <div tagxxx="graphic"></div>
         </div>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Over the past years, several regulatory elements in 
            <i>MHC2TA</i> promoters and interacting factors that are important for transcriptional activation
            have been identified (Figure 
            <span ref-type="fig" rid="F2">2</span>). IFNγ-mediated activation of CIITA-PIV requires occupation of the gamma-activated
            sequence (GAS)-box and the ISRE in CIITA-PIV by STAT-1 and the STAT-1 target gene
            IRF-1 (Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B61">
               <sup>
                  <a href="#B61">1998</a>
               </sup>
            </span>). Importantly, STAT-1 needs to interact with USF-1 bound to the E-box adjacent to
            the GAS-box for stable interaction (Muhlethaler-Mottet et al., 
            <span ref-type="bibr" rid="B61">
               <sup>
                  <a href="#B61">1998</a>
               </sup>
            </span>; Figure 
            <span ref-type="fig" rid="F2">2</span>). The IFNγ-mediated activation of CIITA-PIV also results in increased histone H3
            and H4 acetylation at CIITA-PIV (Morris et al., 
            <span ref-type="bibr" rid="B58">
               <sup>
                  <a href="#B58">2002</a>
               </sup>
            </span>). Interestingly, this increase in histone acetylation in CIITA-PIV chromatin is already
            noted prior to recruitment of IRF-1 to the CIITA-PIV promoter (Morris et al., 
            <span ref-type="bibr" rid="B58">
               <sup>
                  <a href="#B58">2002</a>
               </sup>
            </span>). In addition to the factors interacting with these CIIT-PIV promoter elements, the
            SWI/SNF ATPase BRG-1 was also found to be an important factor in the IFNγ-mediated
            transcriptional activation of CIITA-PIV because cells that lack expression of BRG-1
            failed to induce CIITA expression following exposure to IFNγ (Pattenden et al., 
            <span ref-type="bibr" rid="B67">
               <sup>
                  <a href="#B67">2002</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Class II transactivator-PIII is employed in B cells and activated T cells in humans
            (Ghosh et al., 
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">1999</a>
               </sup>
            </span>; Holling et al., 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">2002</a>
               </sup>
            </span>; Van der Stoep et al., 
            <span ref-type="bibr" rid="B88">
               <sup>
                  <a href="#B88">2002a</a>
               </sup>
            </span>; Wong et al., 
            <span ref-type="bibr" rid="B91">
               <sup>
                  <a href="#B91">2002</a>
               </sup>
            </span>). Activation of CIITA-PIII requires interaction of the transcription factor CREB-1
            with CRE-binding sites in the activation response element (ARE)-2 and, depending on
            the cellular context, also with CRE-binding sites in the 5′-UTR of CIITA-PIII (Holling
            et al., 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">2002</a>
               </sup>
            </span>; Van der Stoep et al., 
            <span ref-type="bibr" rid="B88">
               <sup>
                  <a href="#B88">2002a</a>
               </sup>
            </span>; Wong et al., 
            <span ref-type="bibr" rid="B91">
               <sup>
                  <a href="#B91">2002</a>
               </sup>
            </span>). The CREB-1 mediated activation of CIITA-PIII in B cells was amplified by the KAT
            CBP (Van der Stoep et al., 
            <span ref-type="bibr" rid="B88">
               <sup>
                  <a href="#B88">2002a</a>
               </sup>
            </span>). CIITA-PIII also contains a composite Ets/ISRE-consensus element (Site C) and 2
            E-box motifs, which were found to play a crucial role in its B cell-specific transcriptional
            regulation (Van der Stoep et al., 
            <span ref-type="bibr" rid="B87">
               <sup>
                  <a href="#B87">2004</a>
               </sup>
            </span>). In B cells the Ets/ISRE-consensus element is bound by PU.1 and IRF-4, whereas the
            basic helix-loop-helix factor E47 interacts with the E-box motifs. When bound respectively
            to the Ets/ISRE and E-boxes PU.1 and IRF-4, and E47 synergize to direct B cell-specific
            activation of CIITA-PIII (Figure 
            <span ref-type="fig" rid="F2">2</span>; Van der Stoep et al., 
            <span ref-type="bibr" rid="B87">
               <sup>
                  <a href="#B87">2004</a>
               </sup>
            </span>). The involvement of these factors in B cell-specific activation of CIITA-PIII is
            of interest because PU.1, IRF-4, and E47 also play an important role in B cell differentiation
            and activation.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <i>In vivo</i> footprint analysis of CIITA-PI in immature dendritic cells revealed multiple protein/DNA
            interactions that were lost upon maturation of dendritic cells. CIITA-PI was found
            to contain binding sites for PU.1, Sp-1 NF-κB, and a composite Ets/ISRE (Figure 
            <span ref-type="fig" rid="F2">2</span>; Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). Transcription mediated by CIITA-PI in immature dendritic cells requires binding
            of PU.1, IRF-8, NF-κB, and Sp-1 to the promoter (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). Interestingly, for binding of PU.1 to the composite Ets/ISRE heterodimerization
            with IRF-8 is a prerequisite. Mutational analysis of the PU.1, IRF-8, and NF-κB sites
            showed that these sites were critical for transcriptional activity of CIITA-PI. Of
            note is also that mice lacking IRF-8 displayed an unoccupied CIITA-PI, which was restored
            by reconstitution with IRF-8 
            <i>in vitro</i> (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). Together, these observations reveal an important role for PU.1/IRF-8 in the activation
            of CIITA-PI in immature dendritic cells.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasma B cells lack expression of CIITA (Silacci et al., 
            <span ref-type="bibr" rid="B75">
               <sup>
                  <a href="#B75">1994</a>
               </sup>
            </span>). This extinction of CIITA and resulting MHC-II molecule expression during differentiation
            of B cells into plasma B cells is mediated by the transcriptional repressor B lymphocyte-induced
            maturation protein-1 (Blimp-1, also known as positive regulatory domain I-binding
            factor 1, PRDI-BF1; Piskurich et al., 
            <span ref-type="bibr" rid="B68">
               <sup>
                  <a href="#B68">2000</a>
               </sup>
            </span>; Ghosh et al., 
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">2001</a>
               </sup>
            </span>). The silencing of CIITA expression in plasma cells is most likely resulting from
            binding of Blimp-1 to the Ets/ISRE-consensus element in CIITA-PIII thereby disrupting
            the interaction of PU.1/IRF-4 to this element (Piskurich et al., 
            <span ref-type="bibr" rid="B68">
               <sup>
                  <a href="#B68">2000</a>
               </sup>
            </span>; Ghosh et al., 
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">2001</a>
               </sup>
            </span>; Wright and Ting, 
            <span ref-type="bibr" rid="B92">
               <sup>
                  <a href="#B92">2006</a>
               </sup>
            </span>). Interestingly, besides its repressive activity on CIITA-PIII transactivation, there
            is more recent evidence that PRDI-BF1 mediates also repression of CIITA-PIV (Chen
            et al., 
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">2007</a>
               </sup>
            </span>). Transcriptional repression of 
            <i>MHC2TA</i> mediated by Blimp-1/PRDI-BF1 is also associated with histone deacetylase and lysine
            methyltransferase (KMT) activities (Yu et al., 
            <span ref-type="bibr" rid="B94">
               <sup>
                  <a href="#B94">2000</a>
               </sup>
            </span>; Gyory et al., 
            <span ref-type="bibr" rid="B25">
               <sup>
                  <a href="#B25">2004</a>
               </sup>
            </span>). In particular the activities of the histone deacetylases HDAC1 and HDAC2, and the
            lysine methyltransferase KMT1C (also known as G9a), are required in these epigenetic
            silencing processes. Indeed it was demonstrated by chromatin immunoprecipitation (ChIP)
            that differences between B cells and plasma cells exist in the levels of activating
            and repressive histone marks in CIITA-PIII chromatin (Green et al., 
            <span ref-type="bibr" rid="B24">
               <sup>
                  <a href="#B24">2006</a>
               </sup>
            </span>). In plasma cells lacking CIITA expression, histone marks associated with gene transcription
            such as acetylated histone H3 and H4, and 2meK4-H3 and 3meK4-H3 are lost at CIITA-PIII,
            while the repressive 2meK9-H3 mark is increased (Green et al., 
            <span ref-type="bibr" rid="B24">
               <sup>
                  <a href="#B24">2006</a>
               </sup>
            </span>). Interestingly these histone marks were found also to exist at CIITA-PI, CIITA-PII
            and CIITA-PIV, revealing the involvement of the entire 
            <i>MHC2TA</i> multi-promoter region. As a consequence of the repressive histone marks and resulting
            chromatin inaccessibility, the binding of CIITA-PIII interacting transcription factors
            (i.e., Sp-1, CREB-1, E47, PU.1, IRF-4) was lost in plasma cells (Green et al., 
            <span ref-type="bibr" rid="B24">
               <sup>
                  <a href="#B24">2006</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In dendritic cell maturation chromatin remodeling also plays an important role in
            the control of 
            <i>MHC2TA</i> transcription (Landmann et al., 
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">2001</a>
               </sup>
            </span>; Choi et al., 
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">2009</a>
               </sup>
            </span>). During differentiation of monocytes into immature dendritic cells the CIITA-PI
            isoform is induced. In immature dendritic cells, MHC-II molecules are largely retained
            in intracellular compartments. Upon maturation of dendritic cells, the peptide/MHC-II
            complexes are assembled and transported to the cell surface. The increase of transported
            MHC-II molecules at the cell surface is accompanied by rapid transcriptional silencing
            of 
            <i>MHC2TA</i> in matured dendritic cells (Landmann et al., 
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">2001</a>
               </sup>
            </span>). Like in plasma B cells, the transcriptional inactivation of CIITA-PI is also accompanied
            by global histone deacetylation involving not only CIITA-PI but also CIITA-PIII and
            CIITA-PIV (Landmann et al., 
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">2001</a>
               </sup>
            </span>). In a mouse model activation of CIITA-PI, during differentiation of monocytes into
            dendritic cells by mGM-CSF, is accompanied by an increase in the levels of acetylated
            histone H3 and H4 (Choi et al., 
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">2009</a>
               </sup>
            </span>). IL-10 could block the increase in histone H3 and H4 acetylation during differentiation
            resulting in inhibition of 
            <i>MHC2TA</i> transcription (Choi et al., 
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">2009</a>
               </sup>
            </span>). Recently the involvement of the transcriptional repressor PRD1-BF1/Blimp-1 in these
            CIITA-PI silencing processes was revealed (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). It was shown that during dendritic cell maturation binding to CIITA-PI of the transcriptional
            activators PU.1, IRF-8, NF-κB, and Sp-1 is lost while at the same time the transcriptional
            repressor PRD1-BF1/Blimp-1 and its associated co-repressors KMT1C and HDAC2 are recruited
            to CIITA-PI (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). This results in a loss of histone acetylation and acquisition of histone K9-H3
            dimethylation and heterochromatin protein 1γ (HP1γ) at CIITA-PI (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>). Together, the transcriptional repressor PRD1-BF1/Blimp-1 appears to play a central
            role in the extinction of the various CIITA promoters and therefore can be regarded
            as a central regulator of MHC-II antigen presentation (Smith et al., 
            <span ref-type="bibr" rid="B76">
               <sup>
                  <a href="#B76">2011</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Distal elements and chromatin remodeling also play an essential role in the transcriptional
            regulation of 
            <i>MHC2TA</i> (Ni et al., 
            <span ref-type="bibr" rid="B66">
               <sup>
                  <a href="#B66">2008</a>
               </sup>
            </span>). Transcriptional activation of CIITA-PIV by IFNγ relies on the interaction with
            distal elements at −50 and −8 kb (Ni et al., 
            <span ref-type="bibr" rid="B66">
               <sup>
                  <a href="#B66">2008</a>
               </sup>
            </span>). Contact was also detected between elements at −50 and −16 kb. In these long-range
            interactions, BRG-1, the ATPase driving the chromatin remodeling complex SWI-SNF (also
            called BAF), was constitutively bound to sites at −50, −16, −8, and +59 kb, and also
            CIITA-IV (Ni et al., 
            <span ref-type="bibr" rid="B66">
               <sup>
                  <a href="#B66">2008</a>
               </sup>
            </span>). Thus BRG-1 not only is an important factor in the CIITA-mediated activation of
            
            <i>MHC-II</i> genes, but also controls the transcriptional activation of 
            <i>MHC2TA</i> itself through long-range chromatin and promoter interactions.
         </p>
      </div>
      <div id="">
         <h2>Extinction of MHC-II Expression in Cancer</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As discussed in the previous sections lack of MHC-II molecule expression coincides
            with lack of detectable levels of CIITA. In cancer the transcriptional silencing of
            
            <i>MHC2TA</i> and resulting extinction of 
            <i>MHC-II</i> gene expression is frequently noted (Murphy and Tomasi, 
            <span ref-type="bibr" rid="B64">
               <sup>
                  <a href="#B64">1998</a>
               </sup>
            </span>; Yazawa et al., 
            <span ref-type="bibr" rid="B93">
               <sup>
                  <a href="#B93">1999</a>
               </sup>
            </span>; Meissner et al., 
            <span ref-type="bibr" rid="B53">
               <sup>
                  <a href="#B53">2008</a>
               </sup>
            </span>; Berghuis et al., 
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">2009</a>
               </sup>
            </span>). The silencing of CIITA is mostly mediated by chromatin modifications involving
            methylation of DNA and modifications of histones. The lack of CIITA expression in
            several cancer types is associated with CpG dinucleotide methylation of CIITA-PIV
            and of CIITA-PIII DNA (Morris et al., 
            <span ref-type="bibr" rid="B59">
               <sup>
                  <a href="#B59">2000</a>
               </sup>
            </span>; Van den Elsen et al., 
            <span ref-type="bibr" rid="B85">
               <sup>
                  <a href="#B85">2000</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B84">
               <sup>
                  <a href="#B84">2003</a>
               </sup>
            </span>; Van der Stoep et al., 
            <span ref-type="bibr" rid="B89">
               <sup>
                  <a href="#B89">2002b</a>
               </sup>
            </span>; Holling et al., 
            <span ref-type="bibr" rid="B29">
               <sup>
                  <a href="#B29">2004</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B31">
               <sup>
                  <a href="#B31">2006</a>
               </sup>
            </span>; Morimoto et al., 
            <span ref-type="bibr" rid="B57">
               <sup>
                  <a href="#B57">2004</a>
               </sup>
            </span>; Satoh et al., 
            <span ref-type="bibr" rid="B73">
               <sup>
                  <a href="#B73">2004</a>
               </sup>
            </span>; De Lerma Barbaro et al., 
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">2008</a>
               </sup>
            </span>; Meissner et al., 
            <span ref-type="bibr" rid="B53">
               <sup>
                  <a href="#B53">2008</a>
               </sup>
            </span>). Besides CpG dinucleotide methylation, the lack of IFNγ-induced transcription of
            
            <i>MHC2TA</i> is also associated with histone deacetylase activities (Magner et al., 
            <span ref-type="bibr" rid="B44">
               <sup>
                  <a href="#B44">2000</a>
               </sup>
            </span>; Murphy et al., 
            <span ref-type="bibr" rid="B63">
               <sup>
                  <a href="#B63">2002</a>
               </sup>
            </span>; Holtz et al., 
            <span ref-type="bibr" rid="B32">
               <sup>
                  <a href="#B32">2003</a>
               </sup>
            </span>; Kanaseki et al., 
            <span ref-type="bibr" rid="B36">
               <sup>
                  <a href="#B36">2003</a>
               </sup>
            </span>; Chou et al., 
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">2005</a>
               </sup>
            </span>).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In a uveal melanoma tumor cell line it was demonstrated for the first time that histone
            methylation played an important role in 
            <i>MHC2TA</i> transcriptional silencing (Holling et al., 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">2007</a>
               </sup>
            </span>). The strongly reduced expression levels of CIITA after IFNγ-induction were found
            to correlate with high levels of the repressive 3meK27-H3 histone modification in
            CIITA-PIV chromatin in the absence of CpG dinucleotide methylation of CIITA-PIV DNA
            (Holling et al., 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">2007</a>
               </sup>
            </span>). Moreover, the KMTase Enhancer of Zeste Homolog 2 (EZH2, or KMT6) was recruited
            to relative high levels into CIITA-PIV chromatin (Holling et al., 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">2007</a>
               </sup>
            </span>). KMT6 is the catalytic subunit of the polycomb repressive complex 2 (PRC2), which
            plays an important role in transcriptional silencing and maintenance of cellular identity.
            Consistent with the transcriptional silent state of 
            <i>MHC2TA</i> was the lack of RNA polymerase II recruitment into CIITA-PIV chromatin after IFNγ-induction
            (Holling et al., 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">2007</a>
               </sup>
            </span>). RNA interference-mediated silencing of expression of KMT6 resulted in an increment
            in CIITA mRNA expression levels after IFNγ induction. These observations suggest that
            KMT6 is involved in the transcriptional downregulation of IFNγ-induced expression
            of CIITA in uveal melanoma (Holling et al., 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">2007</a>
               </sup>
            </span>). Notably, the transcriptional silencing of 
            <i>MHC2TA</i> by histone methylation in the absence of CpG dinucleotide methylation is in line
            with the observation that the 3meK27-H3 modification pre-marks genes for 
            <i>de novo</i> methylation in cancer (Schlesinger et al., 
            <span ref-type="bibr" rid="B74">
               <sup>
                  <a href="#B74">2007</a>
               </sup>
            </span>). It could therefore be argued that the epigenetic make-up of the CIITA-PIV region
            in uveal melanoma reflects pre-marking for 
            <i>de novo</i> methylation of DNA, and that this reflects an intermediate epigenetic state of 
            <i>MHC2TA</i> in the complete shut down of MHC-II mediated antigen presentation functions. More
            recently, lack of CIITA expression was also found associated with high levels of the
            3meK27-H3 repressive histone mark in the relative absence of activating histone acetylation
            and methylation marks in CIITA-PIII chromatin in T leukemia cell lines lacking MHC-II
            molecule expression (Van Eggermond et al., 
            <span ref-type="bibr" rid="B90">
               <sup>
                  <a href="#B90">2011</a>
               </sup>
            </span>). In contrast, CIITA and MHC-II molecule expressing T lymphoma cells displayed the
            opposite phenotype. As detailed above, in T leukemia cells these repressive histone
            marks were also found to be associated with the other CIITA promoters in the 
            <i>MHC2TA</i> multi-promoter region, while the opposite was noted for T lymphoma cells (Van Eggermond
            et al., 
            <span ref-type="bibr" rid="B90">
               <sup>
                  <a href="#B90">2011</a>
               </sup>
            </span>). The high levels of the repressive histone mark 3meK27-H3 were accompanied by relative
            high levels of KMT6 at the various CIITA promoters in T leukemia cells, while CIITA
            expressing T lymphoma cells displayed a general lack of KMT6 (Van Eggermond et al.,
            
            <span ref-type="bibr" rid="B90">
               <sup>
                  <a href="#B90">2011</a>
               </sup>
            </span>). Additionally, in HeLa cervical carcinoma cells a role for KMT6 in transcriptional
            silencing of IFNγ-inducible expression of CIITA was also revealed (Mehta et al., 
            <span ref-type="bibr" rid="B52">
               <sup>
                  <a href="#B52">2011</a>
               </sup>
            </span>). Together, these observations provide a clear link with expression of Polycomb Group
            proteins and transcriptional silencing of 
            <i>MHC2TA</i> and resulting lack of expression of MHC-II molecules in cancer.
         </p>
      </div>
      <div id="">
         <h2>Conclusion</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Constitutive and induced transcription of 
            <i>MHC-I</i> and 
            <i>MHC-II</i> genes is mediated by a set of conserved regulatory elements in their promoters and
            interacting transcription factors of which the SXY-module is shared by both sets of
            genes. CIITA plays an essential role in the control of constitutive and induced 
            <i>MHC-II</i> gene transcription through its interaction with the MHC-enhanceosome bound to the
            conserved SXY-module in MHC-II promoters. When bound to the MHC-enhanceosome, CIITA
            acts as a platform recruiting various activities involved in histone acetylation/deacetylation
            and methylation. CIITA is also central to recruitment of more general chromatin remodeling
            activities and long-range chromatin interactions of MHC-II promoters with distal elements.
            These activities mediated by CIITA provide strict control of transcription of these
            important immune genes. An additional level of transcriptional control for 
            <i>MHC-II</i> gene expression is at the level of 
            <i>MHC2TA</i>, the gene encoding CIITA, which is also tightly regulated by both genetic and epigenetic
            mechanisms. Because of the involvement of epigenetic mechanisms in the transcriptional
            control of 
            <i>MHC</i> genes, deviations in these epigenetic mechanisms as observed under pathological conditions
            such as in cancer and autoimmune disease might provide an opportunity for pharmacological
            interference targeting the enzymes that modify DNA and histones.
         </p>
      </div>
      <div id="">
         <h2>Conflict of Interest Statement</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The author declares that the research was conducted in the absence of any commercial
            or financial relationships that could be construed as a potential conflict of interest.
         </p>
      </div>
      <div tagxxx="back">
         <div tagxxx="ack">
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Support of the research of PJvdE was obtained from the Dutch Cancer Society and the
               Dutch MS Research Foundation. I greatly acknowledge the contributions of all the past
               and present members of the laboratory, and national and international collaborators.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <div tagxxx="title">References</div>
               <li tag="ref">
                  <a name="B1"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Berghuis</span>
                           <span tagx="given-names">D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">De Hooge</span>
                           <span tagx="given-names">A. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Santos</span>
                           <span tagx="given-names">S. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Horst</span>
                           <span tagx="given-names">D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wiertz</span>
                           <span tagx="given-names">E. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Taminiau</span>
                           <span tagx="given-names">A. H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ottaviano</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Schaefer</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Dirksen</span>
                           <span tagx="given-names">U.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hooijberg</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mulder</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Melief</span>
                           <span tagx="given-names">C. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Egeler</span>
                           <span tagx="given-names">R. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Schilham</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Jordanova</span>
                           <span tagx="given-names">E. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hogendoorn</span>
                           <span tagx="given-names">P. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Lankester</span>
                           <span tagx="given-names">A. C.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications
                        for immune recognition
                     </span>. 
                     <span tagx="source">J. Pathol.</span>
                     <span tagx="volume">218</span>, 
                     <span tagx="fpage">222</span>–
                     <span tagx="lpage">231</span>
                     <span class="pub-id'">[10.1002/path.2537]</span>
                     <span class="pub-id'">[19274709]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Bhat</span>
                           <span tagx="given-names">K. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Brooks</span>
                           <span tagx="given-names">J. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010a</span>). 
                     <span tagx="article-title">Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA
                        is essential for CIITA stability and MHC class II expression
                     </span>. 
                     <span tagx="source">Immunol. Cell Biol.</span>
                     <span tagx="volume">88</span>, 
                     <span tagx="fpage">807</span>–
                     <span tagx="lpage">816</span>
                     <span class="pub-id'">[10.1038/icb.2010.45]</span>
                     <span class="pub-id'">[20351748]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Bhat</span>
                           <span tagx="given-names">K. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010b</span>). 
                     <span tagx="article-title">Phosphorylation and ubiquitination of degron proximal residues are essential for class
                        II transactivator (CIITA) transactivation and major histocompatibility class II expression
                     </span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">285</span>, 
                     <span tagx="fpage">25893</span>–
                     <span tagx="lpage">25903</span>
                     <span class="pub-id'">[10.1074/jbc.M110.127746]</span>
                     <span class="pub-id'">[20538595]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Bhat</span>
                           <span tagx="given-names">K. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Turner</span>
                           <span tagx="given-names">J. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Myers</span>
                           <span tagx="given-names">S. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Cape</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription</span>. 
                     <span tagx="source">Mol. Immunol.</span>
                     <span tagx="volume">45</span>, 
                     <span tagx="fpage">2214</span>–
                     <span tagx="lpage">2224</span>
                     <span class="pub-id'">[10.1016/j.molimm.2007.12.001]</span>
                     <span class="pub-id'">[18215421]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Chen</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gilbert</span>
                           <span tagx="given-names">C. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hudson</span>
                           <span tagx="given-names">J. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bolick</span>
                           <span tagx="given-names">S. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">Positive regulatory domain I-binding factor 1 mediates repression of the MHC class
                        II transactivator (CIITA) type IV promoter
                     </span>. 
                     <span tagx="source">Mol. Immunol.</span>
                     <span tagx="volume">44</span>, 
                     <span tagx="fpage">1461</span>–
                     <span tagx="lpage">1470</span>
                     <span class="pub-id'">[10.1016/j.molimm.2006.04.026]</span>
                     <span class="pub-id'">[16765445]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Choi</span>
                           <span tagx="given-names">N. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Majumder</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Regulation of major histocompatibility complex class II genes</span>. 
                     <span tagx="source">Curr. Opin. Immunol.</span>
                     <span tagx="volume">23</span>, 
                     <span tagx="fpage">81</span>–
                     <span tagx="lpage">87</span>
                     <span class="pub-id'">[10.1016/j.coi.2010.09.007]</span>
                     <span class="pub-id'">[20970972]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Choi</span>
                           <span tagx="given-names">Y. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yu</span>
                           <span tagx="given-names">H. N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yoon</span>
                           <span tagx="given-names">C. H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bae</span>
                           <span tagx="given-names">Y. S.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">Tumor-mediated down-regulation of MHC class II in DC development is attributable to
                        the epigenetic control of the CIITA type I promoter
                     </span>. 
                     <span tagx="source">Eur. J. Immunol.</span>
                     <span tagx="volume">39</span>, 
                     <span tagx="fpage">858</span>–
                     <span tagx="lpage">868</span>
                     <span class="pub-id'">[10.1002/eji.200838674]</span>
                     <span class="pub-id'">[19224634]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Chou</span>
                           <span tagx="given-names">S. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Khan</span>
                           <span tagx="given-names">A. N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Magner</span>
                           <span tagx="given-names">W. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tomasi</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">Histone acetylation regulates the cell type specific CIITA promoters, MHC class II
                        expression and antigen presentation in tumor cells
                     </span>. 
                     <span tagx="source">Int. Immunol.</span>
                     <span tagx="volume">17</span>, 
                     <span tagx="fpage">1483</span>–
                     <span tagx="lpage">1494</span>
                     <span class="pub-id'">[10.1093/intimm/dxh326]</span>
                     <span class="pub-id'">[16210330]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Chou</span>
                           <span tagx="given-names">S. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tomasi</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Spatial distribution of histone methylation during MHC class II expression</span>. 
                     <span tagx="source">Mol. Immunol.</span>
                     <span tagx="volume">45</span>, 
                     <span tagx="fpage">971</span>–
                     <span tagx="lpage">980</span>
                     <span class="pub-id'">[10.1016/j.molimm.2007.10.033]</span>
                     <span class="pub-id'">[17850872]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">De Lerma Barbaro</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">De Ambrosis</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Banelli</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Li Pira</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Aresu</span>
                           <span tagx="given-names">O.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Romani</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ferrini</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Accolla</span>
                           <span tagx="given-names">R. S.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in
                        promyelocytic cells
                     </span>. 
                     <span tagx="source">Int. Immunol.</span>
                     <span tagx="volume">20</span>, 
                     <span tagx="fpage">1457</span>–
                     <span tagx="lpage">1466</span>
                     <span class="pub-id'">[10.1093/intimm/dxn103]</span>
                     <span class="pub-id'">[18829986]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Durand</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sperisen</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Emery</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Barras</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zufferey</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency</span>. 
                     <span tagx="source">EMBO J.</span>
                     <span tagx="volume">16</span>, 
                     <span tagx="fpage">1045</span>–
                     <span tagx="lpage">1055</span>
                     <span class="pub-id'">[10.1093/emboj/16.5.1045]</span>
                     <span class="pub-id'">[9118943]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Flajollet</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Poras</span>
                           <span tagx="given-names">I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Carosella</span>
                           <span tagx="given-names">E. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Moreau</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">RREB-1 is a transcriptional repressor of HLA-G</span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">183</span>, 
                     <span tagx="fpage">6948</span>–
                     <span tagx="lpage">6959</span>
                     <span class="pub-id'">[10.4049/jimmunol.0902053]</span>
                     <span class="pub-id'">[19890057]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Fontes</span>
                           <span tagx="given-names">J. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kanazawa</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Jean</span>
                           <span tagx="given-names">D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peterlin</span>
                           <span tagx="given-names">B. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">Interactions between the class II transactivator and CREB binding protein increase
                        transcription of major histocompatibility complex class II genes
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">19</span>, 
                     <span tagx="fpage">941</span>–
                     <span tagx="lpage">947</span>
                     <span class="pub-id'">[9858618]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Ghosh</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gyory</span>
                           <span tagx="given-names">I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wood</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">Positive regulatory domain I binding factor 1 silences class II transactivator expression
                        in multiple myeloma cells
                     </span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">276</span>, 
                     <span tagx="fpage">15264</span>–
                     <span tagx="lpage">15268</span>
                     <span class="pub-id'">[10.1074/jbc.M008831200]</span>
                     <span class="pub-id'">[11279146]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Ghosh</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hassani</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">A novel element and a TEF-2-like element activate the major histocompatibility complex
                        class II transactivator in B-lymphocytes
                     </span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">274</span>, 
                     <span tagx="fpage">32342</span>–
                     <span tagx="lpage">32350</span>
                     <span class="pub-id'">[10.1074/jbc.274.45.32342]</span>
                     <span class="pub-id'">[10542275]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Girdlestone</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Synergistic induction of HLA class I expression by RelA and CIITA</span>. 
                     <span tagx="source">Blood</span>
                     <span tagx="volume">95</span>, 
                     <span tagx="fpage">3804</span>–
                     <span tagx="lpage">3808</span>
                     <span class="pub-id'">[10845913]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peijnenburg</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Keijsers</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation:
                        the ISRE-mediated route and a novel pathway involving CIITA
                     </span>. 
                     <span tagx="source">Immunity</span>
                     <span tagx="volume">6</span>, 
                     <span tagx="fpage">601</span>–
                     <span tagx="lpage">611</span>
                     <span class="pub-id'">[10.1016/S1074-7613(00)80348-9]</span>
                     <span class="pub-id'">[9175838]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Biesta</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">De Steenwinkel</span>
                           <span tagx="given-names">J. E. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Datema</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">CREB provides for an alternative pathway of HLA-G transactivation</span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">277</span>, 
                     <span tagx="fpage">39525</span>–
                     <span tagx="lpage">39531</span>
                     <span class="pub-id'">[10.1074/jbc.M112273200]</span>
                     <span class="pub-id'">[12183445]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Keijsers</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Zutphen</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">The role of enhancer A in the locus-specific transactivation of classical and non-classical
                        MHC class I genes by NF-κB
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">161</span>, 
                     <span tagx="fpage">2276</span>–
                     <span tagx="lpage">2283</span>
                     <span class="pub-id'">[9725221]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">The regulation of HLA class I expression: is HLA-G the odd one out?</span>
                     <span tagx="source">Semin. Cancer Biol.</span>
                     <span tagx="volume">9</span>, 
                     <span tagx="fpage">55</span>–
                     <span tagx="lpage">59</span>
                     <span class="pub-id'">[10.1006/scbi.1998.0109]</span>
                     <span class="pub-id'">[10092551]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Zutphen</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Westerheide</span>
                           <span tagx="given-names">S. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin
                        gene transactivation
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">167</span>, 
                     <span tagx="fpage">5175</span>–
                     <span tagx="lpage">5184</span>
                     <span class="pub-id'">[11673530]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Zutphen</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Woltman</span>
                           <span tagx="given-names">A. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">Transactivation of classical and non-classical HLA class I genes through the interferon-stimulated
                        response element
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">163</span>, 
                     <span tagx="fpage">1428</span>–
                     <span tagx="lpage">1434</span>
                     <span class="pub-id'">[10415043]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gomez</span>
                           <span tagx="given-names">J. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Majumder</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Nagarajan</span>
                           <span tagx="given-names">U. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">X box-like sequences in the MHC class II region maintain regulatory function</span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">175</span>, 
                     <span tagx="fpage">1030</span>–
                     <span tagx="lpage">1040</span>
                     <span class="pub-id'">[16002703]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Green</span>
                           <span tagx="given-names">M. R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yoon</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility</span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">177</span>, 
                     <span tagx="fpage">3865</span>–
                     <span tagx="lpage">3873</span>
                     <span class="pub-id'">[16951349]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Gyory</span>
                           <span tagx="given-names">I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wu</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fejér</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Seto</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing</span>. 
                     <span tagx="source">Nat. Immunol.</span>
                     <span tagx="volume">5</span>, 
                     <span tagx="fpage">299</span>–
                     <span tagx="lpage">308</span>
                     <span class="pub-id'">[10.1038/ni1046]</span>
                     <span class="pub-id'">[14985713]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Harton</span>
                           <span tagx="given-names">J. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Linhoff</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin,
                        nucleotide-binding, and leucine-rich repeat domains
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">169</span>, 
                     <span tagx="fpage">4088</span>–
                     <span tagx="lpage">4093</span>
                     <span class="pub-id'">[12370334]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B27"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bergevoet</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wierda</span>
                           <span tagx="given-names">R. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">Genetic and epigenetic control of the major histocompatibility complex class Ib gene
                        HLA-G in trophoblast cell lines
                     </span>. 
                     <span tagx="source">Ann. N. Y. Acad. Sci.</span>
                     <span tagx="volume">1173</span>, 
                     <span tagx="fpage">538</span>–
                     <span tagx="lpage">544</span>
                     <span class="pub-id'">[10.1111/j.1749-6632.2009.04660.x]</span>
                     <span class="pub-id'">[19758196]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B28"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bergevoet</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wilson</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Schooten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Steenbergen</span>
                           <span tagx="given-names">R. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Snijders</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Jager</span>
                           <span tagx="given-names">M. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal
                        melanoma
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">179</span>, 
                     <span tagx="fpage">5317</span>–
                     <span tagx="lpage">5325</span>
                     <span class="pub-id'">[17911618]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B29"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Schooten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Langerak</span>
                           <span tagx="given-names">A. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">Regulation of MHC class II expression in human T-cell malignancies</span>. 
                     <span tagx="source">Blood</span>
                     <span tagx="volume">103</span>, 
                     <span tagx="fpage">1438</span>–
                     <span tagx="lpage">1444</span>
                     <span class="pub-id'">[10.1182/blood-2003-05-1491]</span>
                     <span class="pub-id'">[14563641]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B30"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Quinten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Activated human T cells accomplish MHC class II expression through T cell-specific
                        occupation of class II transactivator promoter III
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">168</span>, 
                     <span tagx="fpage">763</span>–
                     <span tagx="lpage">770</span>
                     <span class="pub-id'">[11777970]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B31"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Jager</span>
                           <span tagx="given-names">M. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">Epigenetic silencing of MHC2TA transcription in cancer</span>. 
                     <span tagx="source">Biochem. Pharmacol.</span>
                     <span tagx="volume">72</span>, 
                     <span tagx="fpage">1570</span>–
                     <span tagx="lpage">1576</span>
                     <span class="pub-id'">[10.1016/j.bcp.2006.06.034]</span>
                     <span class="pub-id'">[16879803]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B32"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Holtz</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Choi</span>
                           <span tagx="given-names">J. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Petroff</span>
                           <span tagx="given-names">M. G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">S. P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">Class II transactivator (CIITA) promoter methylation does not correlate with silencing
                        of CIITA transcription in trophoblasts
                     </span>. 
                     <span tagx="source">Biol. Reprod.</span>
                     <span tagx="volume">69</span>, 
                     <span tagx="fpage">915</span>–
                     <span tagx="lpage">924</span>
                     <span class="pub-id'">[10.1095/biolreprod.103.017103]</span>
                     <span class="pub-id'">[12748124]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B33"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Jabrane-Ferrat</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Nekrep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tosi</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Esserman</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peterlin</span>
                           <span tagx="given-names">B. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound
                        activators?
                     </span>
                     <span tagx="source">Int. Immunol.</span>
                     <span tagx="volume">15</span>, 
                     <span tagx="fpage">467</span>–
                     <span tagx="lpage">475</span>
                     <span class="pub-id'">[10.1093/intimm/dxg048]</span>
                     <span class="pub-id'">[12663676]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B34"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Jabrane-Ferrat</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Nekrep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tosi</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Esserman</span>
                           <span tagx="given-names">L. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peterlin</span>
                           <span tagx="given-names">B. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Major histocompatibility complex class II transcriptional platform: assembly of nuclear
                        factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">22</span>, 
                     <span tagx="fpage">5616</span>–
                     <span tagx="lpage">5625</span>
                     <span class="pub-id'">[10.1128/MCB.22.15.5616-5625.2002]</span>
                     <span class="pub-id'">[12101253]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B35"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Johnson</span>
                           <span tagx="given-names">D. R.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">Locus-specific constitutive and cytokine induced HLA class I gene expression</span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">170</span>, 
                     <span tagx="fpage">1894</span>–
                     <span tagx="lpage">1902</span>
                     <span class="pub-id'">[12574356]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B36"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Kanaseki</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ikeda</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Takamura</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Toyota</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hirohashi</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tokino</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Himi</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sato</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">Histone deacetylation, but not hypermethylation, modifies class II transactivator
                        and MHC class II gene expression in squamous cell carcinomas
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">170</span>, 
                     <span tagx="fpage">4980</span>–
                     <span tagx="lpage">4985</span>
                     <span class="pub-id'">[12734341]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B37"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Kong</span>
                           <span tagx="given-names">X.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fang</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fang</span>
                           <span tagx="given-names">F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Xu</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2009</span>). 
                     <span tagx="article-title">HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages
                        and smooth muscle cells
                     </span>. 
                     <span tagx="source">J. Mol. Cell. Cardiol.</span>
                     <span tagx="volume">46</span>, 
                     <span tagx="fpage">292</span>–
                     <span tagx="lpage">299</span>
                     <span class="pub-id'">[10.1016/j.yjmcc.2008.10.023]</span>
                     <span class="pub-id'">[19041327]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B38"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Koues</span>
                           <span tagx="given-names">O. I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Dudley</span>
                           <span tagx="given-names">R. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gerhardt</span>
                           <span tagx="given-names">D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bhat</span>
                           <span tagx="given-names">K. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">McNeal</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Regulation of acetylation at the major histocompatibility complex class II proximal
                        promoter by the 19S proteasomal ATPase Sug1
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">28</span>, 
                     <span tagx="fpage">5837</span>–
                     <span tagx="lpage">5850</span>
                     <span class="pub-id'">[10.1128/MCB.00535-08]</span>
                     <span class="pub-id'">[18662994]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B39"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Koues</span>
                           <span tagx="given-names">O. I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mehta</span>
                           <span tagx="given-names">N. T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Dudley</span>
                           <span tagx="given-names">R. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Brooks</span>
                           <span tagx="given-names">J. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">Roles for common MLL/COMPASS subunits and the 19S proteasome in regulating CIITA pIV
                        and MHC class II gene expression and promoter methylation
                     </span>. 
                     <span tagx="source">Epigenetics Chromatin</span>
                     <span tagx="volume">3</span>, 
                     <span tagx="fpage">5</span>
                     <span class="pub-id'">[10.1186/1756-8935-3-5]</span>
                     <span class="pub-id'">[20181089]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B40"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Krawczyk</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peyraud</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Rybtsova</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Masternak</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bucher</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Barras</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">Long distance control of MHC class II expression by multiple distal enhancers regulated
                        by regulatory factor X complex and CIITA
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">173</span>, 
                     <span tagx="fpage">6200</span>–
                     <span tagx="lpage">6210</span>
                     <span class="pub-id'">[15528357]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B41"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Kretsovali</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Agalioti</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Spilianakis</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tzortzakaki</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Merika</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Papamatheakis</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">Involvement of CREB binding protein in expression of major histocompatibility complex
                        class II genes via interaction with the class II transactivator
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">18</span>, 
                     <span tagx="fpage">6777</span>–
                     <span tagx="lpage">6783</span>
                     <span class="pub-id'">[9774691]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B42"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Landmann</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Muhlethaler-Mottet</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bernasconi</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Suter</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Waldburger</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Masternak</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Arrighi</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hauser</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fontana</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">Maturation of dendritic cells is accompanied by rapid transcriptional silencing of
                        class II transactivator (CIITA) expression
                     </span>. 
                     <span tagx="source">J. Exp. Med.</span>
                     <span tagx="volume">194</span>, 
                     <span tagx="fpage">379</span>–
                     <span tagx="lpage">391</span>
                     <span class="pub-id'">[10.1084/jem.194.4.379]</span>
                     <span class="pub-id'">[11514596]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B43"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Louis-Plence</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Moreno</span>
                           <span tagx="given-names">C. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein
                        complex on the conserved regulatory regions of HLA class II genes
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">159</span>, 
                     <span tagx="fpage">3899</span>–
                     <span tagx="lpage">3909</span>
                     <span class="pub-id'">[9378978]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B44"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Magner</span>
                           <span tagx="given-names">W. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kazim</span>
                           <span tagx="given-names">A. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Stewart</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Romano</span>
                           <span tagx="given-names">M. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Catalano</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Grande</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Keiser</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Santaniello</span>
                           <span tagx="given-names">F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tomasi</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors</span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">165</span>, 
                     <span tagx="fpage">7017</span>–
                     <span tagx="lpage">7024</span>
                     <span class="pub-id'">[11120829]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B45"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Majumder</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">CTCF controls expression and chromatin architecture of the human major histocompatibility
                        complex class II locus
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">30</span>, 
                     <span tagx="fpage">4211</span>–
                     <span tagx="lpage">4223</span>
                     <span class="pub-id'">[10.1128/MCB.00327-10]</span>
                     <span class="pub-id'">[20584980]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B46"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Majumder</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gomez</span>
                           <span tagx="given-names">J. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are
                        separated by a CTCF-binding enhancer-blocking element
                     </span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">281</span>, 
                     <span tagx="fpage">18435</span>–
                     <span tagx="lpage">18443</span>
                     <span class="pub-id'">[10.1074/jbc.M601155200]</span>
                     <span class="pub-id'">[16675454]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B47"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Majumder</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gomez</span>
                           <span tagx="given-names">J. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Chadwick</span>
                           <span tagx="given-names">B. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">The insulator factor CTCF controls MHC class II gene expression and is required for
                        the formation of long-distance chromatin interactions
                     </span>. 
                     <span tagx="source">J. Exp. Med.</span>
                     <span tagx="volume">205</span>, 
                     <span tagx="fpage">785</span>–
                     <span tagx="lpage">798</span>
                     <span class="pub-id'">[10.1084/jem.20071843]</span>
                     <span class="pub-id'">[18347100]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B48"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Martin</span>
                           <span tagx="given-names">B. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Chin</span>
                           <span tagx="given-names">K. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Olsen</span>
                           <span tagx="given-names">J. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Skinner</span>
                           <span tagx="given-names">C. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Dey</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ozato</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">Induction of MHC class I expression by the MHC class II transactivator CIITA</span>. 
                     <span tagx="source">Immunity</span>
                     <span tagx="volume">6</span>, 
                     <span tagx="fpage">591</span>–
                     <span tagx="lpage">600</span>
                     <span class="pub-id'">[10.1016/S1074-7613(00)80347-7]</span>
                     <span class="pub-id'">[9175837]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B49"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Masternak</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Barras</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zufferey</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Conrad</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Corthals</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Aebersold</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sanchez</span>
                           <span tagx="given-names">J. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hochstrasser</span>
                           <span tagx="given-names">D. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">A gene encoding a novel RFX-associated transactivator is mutated in the majority of
                        MHC class II deficiency patients
                     </span>. 
                     <span tagx="source">Nat. Genet.</span>
                     <span tagx="volume">20</span>, 
                     <span tagx="fpage">273</span>–
                     <span tagx="lpage">277</span>
                     <span class="pub-id'">[10.1038/3081]</span>
                     <span class="pub-id'">[9806546]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B50"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Masternak</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Muhlethaler-Mottet</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Villard</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zufferey</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Steimle</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">CIITA is a transcriptional coactivator that is recruited to MHC class II promoters
                        by multiple synergistic interactions with an enhanceosome complex
                     </span>. 
                     <span tagx="source">Genes Dev.</span>
                     <span tagx="volume">14</span>, 
                     <span tagx="fpage">1156</span>–
                     <span tagx="lpage">1166</span>
                     <span class="pub-id'">[10809673]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B51"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Masternak</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Peyraud</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Krawczyk</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Barras</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">Chromatin remodeling and extragenic transcription at the MHC class II locus control
                        region
                     </span>. 
                     <span tagx="source">Nat. Immunol.</span>
                     <span tagx="volume">4</span>, 
                     <span tagx="fpage">132</span>–
                     <span tagx="lpage">137</span>
                     <span class="pub-id'">[10.1038/ni883]</span>
                     <span class="pub-id'">[12524537]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B52"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Mehta</span>
                           <span tagx="given-names">N. T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boyd</span>
                           <span tagx="given-names">N. H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Early epigenetic events regulate the adaptive immune response gene CIITA</span>. 
                     <span tagx="source">Epigenetics</span>
                     <span tagx="volume">6</span>, 
                     <span tagx="fpage">516</span>–
                     <span tagx="lpage">525</span>
                     <span class="pub-id'">[10.4161/epi.6.4.14516]</span>
                     <span class="pub-id'">[21266852]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B53"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Meissner</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Whiteside</span>
                           <span tagx="given-names">T. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Kuik-Romein</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Valesky</span>
                           <span tagx="given-names">E. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kaufmann</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Seliger</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway
                        in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation
                     </span>. 
                     <span tagx="source">Br. J. Dermatol.</span>
                     <span tagx="volume">158</span>, 
                     <span tagx="fpage">930</span>–
                     <span tagx="lpage">940</span>
                     <span class="pub-id'">[10.1111/j.1365-2133.2008.08465.x]</span>
                     <span class="pub-id'">[18284388]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B54"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Meissner</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Biswas</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">K. H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Liu</span>
                           <span tagx="given-names">Y. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bayir</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Iliopoulos</span>
                           <span tagx="given-names">D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kobayashi</span>
                           <span tagx="given-names">K. S.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">NLR family member NLRC5 is a transcriptional regulator of MHC class I genes</span>. 
                     <span tagx="source">Proc. Natl. Acad. Sci. U.S.A.</span>
                     <span tagx="volume">107</span>, 
                     <span tagx="fpage">13794</span>–
                     <span tagx="lpage">13799</span>
                     <span class="pub-id'">[10.1073/pnas.1008684107]</span>
                     <span class="pub-id'">[20639463]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B55"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Moreau</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mouillot</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Rousseau</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Marcou</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Dausset</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Carosella</span>
                           <span tagx="given-names">E. D.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">HLA-G gene repression is reversed by demethylation</span>. 
                     <span tagx="source">Proc. Natl. Acad. Sci. U.S.A.</span>
                     <span tagx="volume">100</span>, 
                     <span tagx="fpage">1191</span>–
                     <span tagx="lpage">1196</span>
                     <span class="pub-id'">[10.1073/pnas.0337539100]</span>
                     <span class="pub-id'">[12552087]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B56"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Moreno</span>
                           <span tagx="given-names">C. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Beresford</span>
                           <span tagx="given-names">G. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Louis-Plence</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Morris</span>
                           <span tagx="given-names">A. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">CREB regulates MHC class II expression in a CIITA-dependent manner</span>. 
                     <span tagx="source">Immunity</span>
                     <span tagx="volume">10</span>, 
                     <span tagx="fpage">143</span>–
                     <span tagx="lpage">151</span>
                     <span class="pub-id'">[10.1016/S1074-7613(00)80015-1]</span>
                     <span class="pub-id'">[10072067]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B57"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Morimoto</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Toyota</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Satoh</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Murai</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mita</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Suzuki</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Takamura</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ikeda</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ishida</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sato</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tokino</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Imai</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">Inactivation of class II transactivator by DNA methylation and histone deacetylation
                        associated with absence of HLA-DR induction by interferon-gamma in haematopoietic
                        tumour cells
                     </span>. 
                     <span tagx="source">Br. J. Cancer</span>
                     <span tagx="volume">90</span>, 
                     <span tagx="fpage">844</span>–
                     <span tagx="lpage">852</span>
                     <span class="pub-id'">[10.1038/sj.bjc.6601602]</span>
                     <span class="pub-id'">[14970863]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B58"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Morris</span>
                           <span tagx="given-names">A. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Beresford</span>
                           <span tagx="given-names">G. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mooney</span>
                           <span tagx="given-names">M. R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Kinetics of a gamma interferon response: expression and assembly of CIITA promoter
                        IV and inhibition by methylation
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">22</span>, 
                     <span tagx="fpage">4781</span>–
                     <span tagx="lpage">4791</span>
                     <span class="pub-id'">[10.1128/MCB.22.13.4781-4791.2002]</span>
                     <span class="pub-id'">[12052885]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B59"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Morris</span>
                           <span tagx="given-names">A. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Spangler</span>
                           <span tagx="given-names">W. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class
                        II gene control
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">164</span>, 
                     <span tagx="fpage">4143</span>–
                     <span tagx="lpage">4149</span>
                     <span class="pub-id'">[10754309]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B60"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Mudhasani</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fontes</span>
                           <span tagx="given-names">J. D.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">The class II transactivator requires brahma-related gene 1 to activate transcription
                        of major histocompatibility complex class II genes
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">22</span>, 
                     <span tagx="fpage">5019</span>–
                     <span tagx="lpage">5026</span>
                     <span class="pub-id'">[10.1128/MCB.22.14.5019-5026.2002]</span>
                     <span class="pub-id'">[12077331]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B61"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Muhlethaler-Mottet</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Di Berardino</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Otten</span>
                           <span tagx="given-names">L. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative
                        interaction between Stat1 and USF-1
                     </span>. 
                     <span tagx="source">Immunity</span>
                     <span tagx="volume">8</span>, 
                     <span tagx="fpage">157</span>–
                     <span tagx="lpage">166</span>
                     <span class="pub-id'">[10.1016/S1074-7613(00)80468-9]</span>
                     <span class="pub-id'">[9491997]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B62"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Muhlethaler-Mottet</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Otten</span>
                           <span tagx="given-names">L. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Steimle</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1997</span>). 
                     <span tagx="article-title">Expression of MHC class II molecules in different cellular and functional compartments
                        is controlled by differential usage of multiple promoters of the transactivator CIITA
                     </span>. 
                     <span tagx="source">EMBO J.</span>
                     <span tagx="volume">16</span>, 
                     <span tagx="fpage">2851</span>–
                     <span tagx="lpage">2860</span>
                     <span class="pub-id'">[10.1093/emboj/16.10.2851]</span>
                     <span class="pub-id'">[9184229]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B63"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">S. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Holtz</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Lewandowski</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tomasi</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fuji</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">DNA alkylating agents alleviate silencing of class II transactivator gene expression
                        in L1210 lymphoma cells
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">169</span>, 
                     <span tagx="fpage">3085</span>–
                     <span tagx="lpage">3093</span>
                     <span class="pub-id'">[12218125]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B64"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">S. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tomasi</span>
                           <span tagx="given-names">T. B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">Absence of MHC class II antigen expression in trophoblast cells results from a lack
                        of class II transactivator (CIITA) gene expression
                     </span>. 
                     <span tagx="source">Mol. Reprod. Dev.</span>
                     <span tagx="volume">51</span>, 
                     <span tagx="fpage">1</span>–
                     <span tagx="lpage">12</span>
                     <span class="pub-id'">[10.1002/(SICI)1098-2795(199809)51:1&lt;1::AID-MRD1&gt;3.3.CO;2-1]</span>
                     <span class="pub-id'">[9712312]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B65"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Nagarajan</span>
                           <span tagx="given-names">U. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Louis-Plence</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">DeSandro</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Nilsen</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bushey</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome,
                        an MHC class II immunodeficiency
                     </span>. 
                     <span tagx="source">Immunity</span>
                     <span tagx="volume">10</span>, 
                     <span tagx="fpage">153</span>–
                     <span tagx="lpage">162</span>
                     <span class="pub-id'">[10.1016/S1074-7613(00)80016-3]</span>
                     <span class="pub-id'">[10072068]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B66"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Ni</span>
                           <span tagx="given-names">Z.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Abou El Hassan</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Xu</span>
                           <span tagx="given-names">Z.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yu</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bremner</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent
                        distal enhancers
                     </span>. 
                     <span tagx="source">Nat. Immunol.</span>
                     <span tagx="volume">9</span>, 
                     <span tagx="fpage">785</span>–
                     <span tagx="lpage">793</span>
                     <span class="pub-id'">[10.1038/ni.1619]</span>
                     <span class="pub-id'">[18500344]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B67"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Pattenden</span>
                           <span tagx="given-names">S. G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Klose</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Karaskov</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bremner</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent</span>. 
                     <span tagx="source">EMBO J.</span>
                     <span tagx="volume">21</span>, 
                     <span tagx="fpage">1978</span>–
                     <span tagx="lpage">1986</span>
                     <span class="pub-id'">[10.1093/emboj/21.8.1978]</span>
                     <span class="pub-id'">[11953317]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B68"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Lin</span>
                           <span tagx="given-names">K. I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Lin</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Calame</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">BLIMP-I mediates extinction of major histocompatibility class II transactivator expression
                        in plasma cells
                     </span>. 
                     <span tagx="source">Nat. Immunol.</span>
                     <span tagx="volume">1</span>, 
                     <span tagx="fpage">526</span>–
                     <span tagx="lpage">532</span>
                     <span class="pub-id'">[10.1038/82788]</span>
                     <span class="pub-id'">[11101876]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B69"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Linhoff</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">Two distinct gamma interferon-inducible promoters of the major histocompatibility
                        complex class II transactivator gene are differentially regulated by STAT1, interferon
                        regulatory factor 1, and transforming growth factor beta
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">19</span>, 
                     <span tagx="fpage">431</span>–
                     <span tagx="lpage">440</span>
                     <span class="pub-id'">[9858567]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B70"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Linhoff</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">White</span>
                           <span tagx="given-names">L. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1998</span>). 
                     <span tagx="article-title">Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma,
                        STAT1, and TGF-beta-regulated expression of the class II transactivator gene
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">160</span>, 
                     <span tagx="fpage">233</span>–
                     <span tagx="lpage">240</span>
                     <span class="pub-id'">[9551976]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B71"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Raval</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Howcroft</span>
                           <span tagx="given-names">T. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Weissman</span>
                           <span tagx="given-names">J. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kirshner</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zhu</span>
                           <span tagx="given-names">X. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yokoyama</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Singer</span>
                           <span tagx="given-names">D. S.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter
                        requirement for TAF(II)250
                     </span>. 
                     <span tagx="source">Mol. Cell</span>
                     <span tagx="volume">7</span>, 
                     <span tagx="fpage">105</span>–
                     <span tagx="lpage">115</span>
                     <span class="pub-id'">[10.1016/S1097-2765(01)00159-9]</span>
                     <span class="pub-id'">[11172716]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B72"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2001</span>). 
                     <span tagx="article-title">The bare lymphocyte syndrome and the regulation of MHC expression</span>. 
                     <span tagx="source">Annu. Rev. Immunol.</span>
                     <span tagx="volume">19</span>, 
                     <span tagx="fpage">331</span>–
                     <span tagx="lpage">373</span>
                     <span class="pub-id'">[10.1146/annurev.immunol.19.1.331]</span>
                     <span class="pub-id'">[11244040]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B73"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Satoh</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Toyota</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ikeda</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Morimoto</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Akino</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mita</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Suzuki</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sasaki</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kanaseki</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Takamura</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Soejima</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Urano</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yanagihara</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Endo</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hinoda</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fujita</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hosokawa</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Sato</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tokino</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Imai</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">Epigenetic inactivation of class II transactivator (CIITA) is associated with the
                        absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer
                        cells
                     </span>. 
                     <span tagx="source">Oncogene</span>
                     <span tagx="volume">23</span>, 
                     <span tagx="fpage">8876</span>–
                     <span tagx="lpage">8886</span>
                     <span class="pub-id'">[10.1038/sj.onc.1208144]</span>
                     <span class="pub-id'">[15467734]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B74"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Schlesinger</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Straussman</span>
                           <span tagx="given-names">R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Keshet</span>
                           <span tagx="given-names">I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Farkash</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hecht</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zimmerman</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Eden</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yakhini</span>
                           <span tagx="given-names">Z.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ben-Shushan</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reubinoff</span>
                           <span tagx="given-names">B. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bergman</span>
                           <span tagx="given-names">Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Simon</span>
                           <span tagx="given-names">I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Cedar</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation
                        in cancer
                     </span>. 
                     <span tagx="source">Nat. Genet.</span>
                     <span tagx="volume">39</span>, 
                     <span tagx="fpage">232</span>–
                     <span tagx="lpage">236</span>
                     <span class="pub-id'">[10.1038/ng1950]</span>
                     <span class="pub-id'">[17200670]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B75"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Silacci</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mottet</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Steimle</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1994</span>). 
                     <span tagx="article-title">Developmental extinction of major histocompatibility complex class II gene expression
                        in plasmocytes is mediated by silencing of the transactivator gene CIITA
                     </span>. 
                     <span tagx="source">J. Exp. Med.</span>
                     <span tagx="volume">180</span>, 
                     <span tagx="fpage">1329</span>–
                     <span tagx="lpage">1336</span>
                     <span class="pub-id'">[10.1084/jem.180.4.1329]</span>
                     <span class="pub-id'">[7931066]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B76"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">M. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wu</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Tailor</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ozato</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Chen</span>
                           <span tagx="given-names">X.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wei</span>
                           <span tagx="given-names">S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator
                        (CIITA) expression during dendritic cell maturation
                     </span>. 
                     <span tagx="source">J. Biol. Chem.</span>
                     <span tagx="volume">286</span>, 
                     <span tagx="fpage">7893</span>–
                     <span tagx="lpage">7904</span>
                     <span class="pub-id'">[10.1074/jbc.M110.194258]</span>
                     <span class="pub-id'">[21216962]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B77"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Spilianakis</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Papamatheakis</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kretsovali</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major
                        histocompatibility complex class II genes
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">20</span>, 
                     <span tagx="fpage">8489</span>–
                     <span tagx="lpage">8498</span>
                     <span class="pub-id'">[10.1128/MCB.20.22.8489-8498.2000]</span>
                     <span class="pub-id'">[11046145]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B78"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Steimle</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Durand</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Barras</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zufferey</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Hadam</span>
                           <span tagx="given-names">M. R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reith</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1995</span>). 
                     <span tagx="article-title">A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency
                        (bare lymphocyte syndrome)
                     </span>. 
                     <span tagx="source">Genes Dev.</span>
                     <span tagx="volume">9</span>, 
                     <span tagx="fpage">1021</span>–
                     <span tagx="lpage">1032</span>
                     <span class="pub-id'">[10.1101/gad.9.9.1021]</span>
                     <span class="pub-id'">[7744245]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B79"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Steimle</span>
                           <span tagx="given-names">V.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Otten</span>
                           <span tagx="given-names">L. A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zufferey</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mach</span>
                           <span tagx="given-names">B.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1993</span>). 
                     <span tagx="article-title">Complementation cloning of an MHC class II transactivator mutated in hereditary MHC
                        class II deficiency (or bare lymphocyte syndrome)
                     </span>. 
                     <span tagx="source">Cell</span>
                     <span tagx="volume">75</span>, 
                     <span tagx="fpage">135</span>–
                     <span tagx="lpage">146</span>
                     <span class="pub-id'">[10.1016/S0092-8674(05)80090-X]</span>
                     <span class="pub-id'">[8402893]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B80"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Trowsdale</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Genetic control of MHC class II expression</span>. 
                     <span tagx="source">Cell</span>
                     <span tagx="volume">109</span>, 
                     <span tagx="fpage">S21</span>–
                     <span tagx="lpage">S33</span>
                     <span class="pub-id'">[10.1016/S0092-8674(02)00696-7]</span>
                     <span class="pub-id'">[11983150]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B81"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Willingham</span>
                           <span tagx="given-names">S. B.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Bergstralh</span>
                           <span tagx="given-names">D. T.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2008</span>). 
                     <span tagx="article-title">NLRs at the intersection of cell death and immunity</span>. 
                     <span tagx="source">Nat. Rev. Immunol.</span>
                     <span tagx="volume">8</span>, 
                     <span tagx="fpage">372</span>–
                     <span tagx="lpage">379</span>
                     <span class="pub-id'">[10.1038/nri2296]</span>
                     <span class="pub-id'">[18362948]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B82"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Truax</span>
                           <span tagx="given-names">A. D.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Koues</span>
                           <span tagx="given-names">O. I.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Mentel</span>
                           <span tagx="given-names">M. K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2010</span>). 
                     <span tagx="article-title">The 19S ATPase S6a (S6′/TBP1) regulates the transcription initiation of class II transactivator</span>. 
                     <span tagx="source">J. Mol. Biol.</span>
                     <span tagx="volume">395</span>, 
                     <span tagx="fpage">254</span>–
                     <span tagx="lpage">269</span>
                     <span class="pub-id'">[10.1016/j.jmb.2009.10.035]</span>
                     <span class="pub-id'">[19853614]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B83"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kuipers</span>
                           <span tagx="given-names">H. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">Transcriptional regulation of antigen presentation</span>. 
                     <span tagx="source">Curr. Opin. Immunol.</span>
                     <span tagx="volume">16</span>, 
                     <span tagx="fpage">67</span>–
                     <span tagx="lpage">75</span>
                     <span class="pub-id'">[10.1016/j.coi.2003.11.018]</span>
                     <span class="pub-id'">[14734112]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B84"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boss</span>
                           <span tagx="given-names">J. M.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">DNA methylation and expression of major histocompatibility complex class I and class
                        II transactivator genes in human developmental tumor cells and in T cell malignancies
                     </span>. 
                     <span tagx="source">Clin. Immunol.</span>
                     <span tagx="volume">109</span>, 
                     <span tagx="fpage">46</span>–
                     <span tagx="lpage">52</span>
                     <span class="pub-id'">[10.1016/S1521-6616(03)00200-6]</span>
                     <span class="pub-id'">[14585275]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B85"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Viëtor</span>
                           <span tagx="given-names">H. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wilson</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Zutphen</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Gobin</span>
                           <span tagx="given-names">S. J. P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Lack of CIITA expression is central to the absence of antigen presentation functions
                        of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter
                        (PIV) of CIITA
                     </span>. 
                     <span tagx="source">Hum. Immunol.</span>
                     <span tagx="volume">61</span>, 
                     <span tagx="fpage">850</span>–
                     <span tagx="lpage">862</span>
                     <span class="pub-id'">[10.1016/S0198-8859(00)00159-2]</span>
                     <span class="pub-id'">[11053628]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B86"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Quinten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Alblas</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Plancke</span>
                           <span tagx="given-names">A.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2007</span>). 
                     <span tagx="article-title">Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human
                        melanoma cell lines is governed by separate regulatory elements within the PIII upstream
                        regulatory region
                     </span>. 
                     <span tagx="source">Mol. Immunol.</span>
                     <span tagx="volume">44</span>, 
                     <span tagx="fpage">2036</span>–
                     <span tagx="lpage">2046</span>
                     <span class="pub-id'">[10.1016/j.molimm.2006.09.013]</span>
                     <span class="pub-id'">[17067677]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B87"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Quinten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Marcondes Rezende</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2004</span>). 
                     <span tagx="article-title">E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II
                        transactivator promoter III (CIITA-PIII)
                     </span>. 
                     <span tagx="source">Blood</span>
                     <span tagx="volume">104</span>, 
                     <span tagx="fpage">2849</span>–
                     <span tagx="lpage">2857</span>
                     <span class="pub-id'">[10.1182/blood-2004-03-0790]</span>
                     <span class="pub-id'">[15242870]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B88"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Quinten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002a</span>). 
                     <span tagx="article-title">Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III:
                        identification of a novel regulatory region in the 5′-untranslated region and an important
                        role for cAMP-responsive element binding protein 1 and activating transcription factor-1
                        in CIITA-promoter III transcriptional activation in B lymphocytes
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">169</span>, 
                     <span tagx="fpage">5061</span>–
                     <span tagx="lpage">5071</span>
                     <span class="pub-id'">[12391222]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B89"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van der Stoep</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Biesta</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Quinten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002b</span>). 
                     <span tagx="article-title">Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through
                        promoter methylation is predominantly found in developmental tumor cell lines
                     </span>. 
                     <span tagx="source">Int. J. Cancer</span>
                     <span tagx="volume">97</span>, 
                     <span tagx="fpage">501</span>–
                     <span tagx="lpage">507</span>
                     <span class="pub-id'">[10.1002/ijc.1623]</span>
                     <span class="pub-id'">[11802213]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B90"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Van Eggermond</span>
                           <span tagx="given-names">M. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Boom</span>
                           <span tagx="given-names">D. R.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Klous</span>
                           <span tagx="given-names">P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Schooten</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Marquez</span>
                           <span tagx="given-names">V. E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wierda</span>
                           <span tagx="given-names">R. J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Holling</span>
                           <span tagx="given-names">T. M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Van den Elsen</span>
                           <span tagx="given-names">P. J.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2011</span>). 
                     <span tagx="article-title">Epigenetic regulation of CIITA expression in human T-cells</span>. 
                     <span tagx="source">Biochem. Pharmacol.</span> [Epub ahead of print] 
                     <span class="pub-id'">[21664896]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B91"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Wong</span>
                           <span tagx="given-names">A. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ghosh</span>
                           <span tagx="given-names">N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">McKinnon</span>
                           <span tagx="given-names">K. P.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Reed</span>
                           <span tagx="given-names">W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Piskurich</span>
                           <span tagx="given-names">J. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2002</span>). 
                     <span tagx="article-title">Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes
                        and cell line
                     </span>. 
                     <span tagx="source">J. Immunol.</span>
                     <span tagx="volume">169</span>, 
                     <span tagx="fpage">3112</span>–
                     <span tagx="lpage">3119</span>
                     <span class="pub-id'">[12218128]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B92"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Wright</span>
                           <span tagx="given-names">K. L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2006</span>). 
                     <span tagx="article-title">Epigenetic regulation of MHC-II and CIITA genes</span>. 
                     <span tagx="source">Trends Immunol.</span>
                     <span tagx="volume">27</span>, 
                     <span tagx="fpage">405</span>–
                     <span tagx="lpage">412</span>
                     <span class="pub-id'">[10.1016/j.it.2006.07.007]</span>
                     <span class="pub-id'">[16870508]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B93"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Yazawa</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Kamma</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fujiwara</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Matsui</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Horiguchi</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Satoh</span>
                           <span tagx="given-names">H.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fujimoto</span>
                           <span tagx="given-names">M.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Yokoyama</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ogata</span>
                           <span tagx="given-names">T.</span>,
                        </span>
                     </span> (
                     <span tagx="year">1999</span>). 
                     <span tagx="article-title">Lack of class II transactivator causes severe deficiency of HLA-DR expression in small
                        cell lung cancer
                     </span>. 
                     <span tagx="source">J. Pathol.</span>
                     <span tagx="volume">187</span>, 
                     <span tagx="fpage">191</span>–
                     <span tagx="lpage">199</span>
                     <span class="pub-id'">[10.1002/(SICI)1096-9896(199901)187:2&lt;191::AID-PATH206&gt;3.0.CO;2-3]</span>
                     <span class="pub-id'">[10365094]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B94"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Yu</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Angelin-Duclos</span>
                           <span tagx="given-names">C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greenwood</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Liao</span>
                           <span tagx="given-names">J.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Calame</span>
                           <span tagx="given-names">K.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase</span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">20</span>, 
                     <span tagx="fpage">2592</span>–
                     <span tagx="lpage">2603</span>
                     <span class="pub-id'">[10.1128/MCB.20.21.7914-7921.2000]</span>
                     <span class="pub-id'">[10713181]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B95"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Zhu</span>
                           <span tagx="given-names">X. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Linhoff</span>
                           <span tagx="given-names">M. W.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">G.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Chin</span>
                           <span tagx="given-names">K. C.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Maity</span>
                           <span tagx="given-names">S. N.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2000</span>). 
                     <span tagx="article-title">Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific
                        regulation of the class II major histocompatibility complex promoter
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">20</span>, 
                     <span tagx="fpage">6051</span>–
                     <span tagx="lpage">6061</span>
                     <span class="pub-id'">[10.1128/MCB.20.14.5216-5226.2000]</span>
                     <span class="pub-id'">[10913187]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B96"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Zika</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Fauquier</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Vandel</span>
                           <span tagx="given-names">L.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA
                        in IFN-gamma-inducible MHC-II gene expression
                     </span>. 
                     <span tagx="source">Proc. Natl. Acad. Sci. U.S.A.</span>
                     <span tagx="volume">102</span>, 
                     <span tagx="fpage">16321</span>–
                     <span tagx="lpage">16326</span>
                     <span class="pub-id'">[10.1073/pnas.0505045102]</span>
                     <span class="pub-id'">[16254053]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B97"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Zika</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Greer</span>
                           <span tagx="given-names">S. F.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Zhu</span>
                           <span tagx="given-names">X. S.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.-Y.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2003</span>). 
                     <span tagx="article-title">Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and
                        major histocompatibility complex class II enhanceosome formation
                     </span>. 
                     <span tagx="source">Mol. Cell. Biol.</span>
                     <span tagx="volume">23</span>, 
                     <span tagx="fpage">3091</span>–
                     <span tagx="lpage">3102</span>
                     <span class="pub-id'">[10.1128/MCB.23.9.3091-3102.2003]</span>
                     <span class="pub-id'">[12697811]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B98"></a>
                  <div tagxxx="mixed-citation">
                     <span class="person-group'">
                        <span class="name'">
                           <span tagx="surname">Zika</span>
                           <span tagx="given-names">E.</span>,
                        </span>
                        <span class="name'">
                           <span tagx="surname">Ting</span>
                           <span tagx="given-names">J. P.</span>,
                        </span>
                     </span> (
                     <span tagx="year">2005</span>). 
                     <span tagx="article-title">Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes</span>. 
                     <span tagx="source">Curr. Opin. Immunol.</span>
                     <span tagx="volume">17</span>, 
                     <span tagx="fpage">58</span>–
                     <span tagx="lpage">64</span>
                     <span class="pub-id'">[10.1016/j.coi.2004.11.008]</span>
                     <span class="pub-id'">[15653312]</span>
                  </div>
               </li>
            </ul>
         </div>
      </div>
   </div>
</html>